Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04253587 · ClinicalTrials.gov registry record · NA

Wayfinding Intervention in High-Fidelity Long-Term Memory

A NA study of Mild Cognitive Impairment and Long-Term Memory Decline, sponsored by University of California, San Francisco.

Completed
Registry status
NA
Development phase
50
Enrollment target
1
Study location

NCT04253587 is a NA study of Mild Cognitive Impairment and Long-Term Memory Decline that has completed, run by University of California, San Francisco. The registered enrollment target is 50 participants, below the 1,270-participant average among 205 other Mild Cognitive Impairment trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04253587, a NA study of Mild Cognitive Impairment and Long-Term Memory Decline, has completed, sponsored by University of California, San Francisco.

COMPLETED
Registry status
NA
Development phase
50 participants
Enrollment target
1
Study location

Study Summary

Therapeutic treatment is yet available for declining memory, which is an impairment affecting the quality of life for many older adults and patients with cognitive impairment. Cognitive training with an immersive video game promises to drive hippocampal-cortical plasticity and associated gains that can restore memory capability or provide therapeutic treatment for memory deficits.

Interventions

  • DEVICE LabyrinthVR
  • DEVICE Placebo Games
  • DEVICE Coherence
  • DEVICE Tablet

Study Locations (1)

California

  • UCSF Mission Bay - San Francisco

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2019-10-01
Est. Completion 2021-12-15
Phase NA

What the Registry Record Tells You About NCT04253587

The ClinicalTrials.gov registry entry for NCT04253587 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,270-participant average among 205 other Mild Cognitive Impairment trials with a reported enrollment target (96% lower). The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Mild Cognitive Impairment appearing as the primary indexed condition, and to 4 interventions - of which LabyrinthVR is the first listed.

NCT04253587 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT04253587 about?

NCT04253587 is a clinical study titled "Wayfinding Intervention in High-Fidelity Long-Term Memory". Therapeutic treatment is yet available for declining memory, which is an impairment affecting the quality of life for many older adults and patients with cognitive impairment. Cognitive training with an immersive video game promises to drive hippocampal-cortical plasticity and associated gains that ...

What is the current status of trial NCT04253587?

This trial is currently completed. It is a NA study. The enrollment target is 50 participants. The study started on 2019-10-01. Estimated completion is 2021-12-15.

What conditions does trial NCT04253587 study?

This clinical trial studies the following conditions: Mild Cognitive Impairment, Long-Term Memory Decline.

What interventions are being tested in trial NCT04253587?

The interventions under investigation include: LabyrinthVR (DEVICE), Placebo Games (DEVICE), Coherence (DEVICE), Tablet (DEVICE).

Who is sponsoring clinical trial NCT04253587?

This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04253587 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Mild Cognitive Impairment

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.